Two Sigma Investments, LP Scopus Bio Pharma Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.6 - $1.7 $18,241 - $51,685	-30,403 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $49,556 - $130,124	30,403 New	30,403 $50,000
Q3 2021 Nov 15, 2021	SELL	$4.0 - $6.99 $125,664 - $219,597	-31,416 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.17 - $10.25 $58,053 - $115,097	-11,229 Reduced 26.33%	31,416 $224,000
Q1 2021 May 17, 2021	BUY	$7.94 - $14.87 $338,601 - $634,131	42,645 New	42,645 $360,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.